Turner syndrome: An update

Endocrinologist

Volumn 15, Issue 1, 2005, Pages 27-36

  Stratakis, Constantine A ^a,b   Rennert, Owen M ^b  

^a Developmental Endocrinology Branch   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adult patients; Genetics; Genotype; Phenotype; Turner syndrome

Indexed keywords

ESTROGEN; RECOMBINANT GROWTH HORMONE;

AORTA COARCTATION; AORTA VALVE; BODY HEIGHT; BONE DENSITY; BONE MATURATION; CARDIOVASCULAR MALFORMATION; CHROMOSOME DELETION; COGNITIVE DEFECT; CYTOGENETICS; DYSCHONDROSTEOSIS; ENZYME DEFECT; GENDER; GENE AMPLIFICATION; GENOTYPE; GONADOBLASTOMA; HEALTH CARE ORGANIZATION; HEARING LOSS; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FUNCTION TEST; METABOLIC DISORDER; MITRAL VALVE; MOLECULAR BIOLOGY; MONOSOMY; MOSAICISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY FUNCTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCTION; REVIEW; SKELETON MALFORMATION; TURNER SYNDROME; X CHROMOSOME; Y CHROMOSOME;

EID: 13144253095     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000152836.30636.a7     Document Type: Review

References (112)

1. Potter P. Hippocrates, Volume VII. Cambridge, MA: Harvard University Press; 1995:95,273.
2. Stratakis CA, Rennert OM. Turner syndrome: molecular and cytogenetics, dysmorphology, endocrine, and other clinical manifestations and their management. Endocrinologist. 1994;4:442-453.
3. Ullrich O. Turner syndrome and status Bonnevie-Ullrich. Am J Hum Genet. 1949;1:179-203.
4. Bainbridge D. The X in Sex: How the X Chromosome Controls Our Lives. Cambridge, MA: Harvard University Press; 2005.
5. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am. 1991;20:121-152.
6. Gravholt GH, Juul S, Naera RW, et al. Prenatal and postnatal prevalence of Turner syndrome: a registry study. BMJ. 1996;312:16-21.
7. Nielsen J, Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser. 1990;26:209-223.
8. Hanton L, Axelrod L, Bakalov V, et al. The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt). 2003;12:971-977.
9. Lippe M. Turner syndrome. In: Sperling MA, ed. Pediatric Endocrinology. Philadelphia, PA: WB Saunders Company; 1996:387-421.
10. Alvarez-Nava F, Soto M, Sanchez MA, et al. Molecular analysis in Turner syndrome. J Pediatr. 2003;142:336-340.
11. Gravholt CH, Fedder J, Naeraa RW, et al. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab. 2000;85:3199-3202.
12. Chu CE, Connor JM, Donaldson MD, et al. Detection of Y mosaicism in patients with Turner's syndrome. J Med Genet. 1995;32:578-580.
13. Elsheikh M, Dunger DB, Conway GS, et al. Turner's syndrome in adulthood. Endocr Rev. 2002;23:120-140.
14. Robinson DO, Dalton P, Jacobs PA, et al. A molecular and FISH analysis of structurally abnormal Y chromosomes in patients with Turner syndrome. J Med Genet. 1999;36:279-284.
15. Page DC. Y chromosome sequences in Turner syndrome and risk of gonadoblastoma or virilization. Lancet. 1994;343:240-242.
16. Coto E, Toral JF, Menendez MJ, et al. PCR-based study of the presence of Y-chromosome sequences in patients with Ullrich-Turner syndrome. Am J Med Genet. 1995;57:393-396.
17. Monroy N, Lopez M, Cervantes A, et al. Microsatellite analysis in Turner syndrome: parental origin of X chromosomes and possible mechanism of formation of abnormal chromosomes. Am J Med Genet. 2002;107:181-189.
18. Davenport ML, Rosenfeld RG. Turner syndrome. In: Radovisk S, MacGillivray MH, eds. Pediatric Endocrinology: A Practical Clinical Guide. Totowa, NJ: Humana Press; 2003:117-137.
19. Frias JL, Davenport ML. Health supervision for children with Turner syndrome. Pediatrics. 2003;111:692-702.
20. Nagel T, Camargo M, Tagatz G, et al. Gonadal tumors in patients with gonadal dysgenesis and sex chromosomal rings and fragments. Am J Obstet Gynecol. 1984;150:76-82.
21. Patsalis PC, Sismani C, Hadjimarcou MI, et al. Detection and incidence of cryptic Y chromosome sequences in Turner syndrome patients. Clin Genet. 1998;53:249-257.
22. Salo P, Ignatius J, Simola KO, et al. Clinical features of nine males with molecularly defined deletions of the Y chromosome long arm. J Med Genet. 1995;32:711-715.
23. Tzancheva M, Kaneva R, Kumanov P, et al. Two male patients with ring Y: definition of an interval in Yq contributing to Turner syndrome. J Med Genet. 1999;36:549-553.
24. Barbaux S, Vilain E, Raoul O, et al. Proximal deletions of the long arm of the Y chromosome suggest a critical region associated with a specific subset of characteristic Turner stigmata. Hum Mol Genet. 1995;4:1565-1568.
25. Graham BH, Bacino CA. Male patient with non-mosaic deleted Y-chromosome and clinical features of Turner syndrome. Am J Med Genet. 2003;119A:234-237.
26. Villaverde MM, Da Silva JA. Turner-mongolism polysyndrome: review of the first eight known cases. JAMA. 1975;234:844-847.
27. Massa G, Vanderschueren-Lodeweyckx M, Fryns JP. Deletion of the short arm of the X chromosome: a hereditary form of Turner syndrome. Eur J Pediatr. 1992;151:893-894.
28. Carothers AD, Frackiewicz A, De Mey R, et al. A collaborative study of the aetiology of Turner syndrome. Ann Hum Genet. 1980;43:355-368.
29. Pescia G, Ferrier PE, Wyss-Hutin D, et al. 45,X Turner's syndrome in monozygotic twin sisters. J Med Genet. 1975;12:390-396.
30. Hassold T, Pettay D, Robinson A, et al. Molecular studies of parental origin and mosaicism in 45,X conceptuses. Hum Genet. 1992;89:647-652.
31. Mathur A, Stekol L, Schatz D, et al. The parental origin of the single X chromosome in Turner syndrome: lack of correlation with parental age or clinical phenotype. Am J Hum Genet. 1991;48:682-686.
32. Kajii T, Ohama K. Inverse maternal age effect in monosomy X. Hum Genet. 1979;51:147-151.
33. Bronshtein M, Zimmer EZ, Blazer S. A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol. 2003;188:1016-1020.
34. Wenstrom KD, Williamson RA, Grant SS. Detection of fetal Turner syndrome with multiple-marker screening. Am J Obstet Gynecol. 1994;170:570-573.
35. Koeberl DD, McGillivray B, Sybert VP. Prenatal diagnosis of 45.X/46, XX mosaicism and 45,X: implications for postnatal outcome. Am J Hum Genet. 1995;57:661-666.
36. Chernausek SD, Attie KM, Cara JF, et al. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height: Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab. 2000;85:2439-2445.
37. Saenger P. Growth-promoting strategies in Turner syndrome. J Clin Endocrinol Metabol. 1999;84:4345-4348.
38. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88:1119-1125.
39. Plotnick L, Attie KM, Blethen SL, et al. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics. 1998;102:479-481.
40. Ranke MB, Lindberg A, Chatelain P, et al, and the KIGS International Board. Kabi International Growth Study: prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models: KIGS International Board: Kabi International Growth Study. J Clin Endocrinol Metab. 2000;85:4212-4218.
41. Haeusler G, Schmitt K, Blumel P, et al. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr. 1996;85:1408-1414.
42. Stahnke N, Keller E, Landy H, the Serono Study Group. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab. 2002;15:129-138.
43. Sybert VP. Adult height in Turner syndrome with and without androgen therapy. J Pediatr. 1984;104:365.
44. Vanderschueren-Lodeweyckx M, Massa G, Maes M, et al. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. J Clin Endocrinol Metab. 1990;70:122-126.
45. Naeraa RW, Nielsen J, Kastrup KW. Growth hormone treatment and 17b-estradiol treatment of Turner girls: 2-year results. Eur J Pediatr. 1994;153:72.
46. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998;101:e11.
47. Gotzsche CO, Krag-Olsen B, Nielsen J, et al. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child. 1994;71:433-436.
48. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's syndrome: Italian Study Group for Turner Syndrome (IS-GTS). J Pediatr. 1998;133:688-692.
49. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998;102:e12.
50. Berdahl LD, Wenstrom KD, Hanson JW. Web neck anomaly and its association with congenital heart disease. Am J Med Genet. 1985;56:304-307.
51. Boucher CA, Sargent CA, Ogata T, et al. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet. 2001;38:591-598.
52. Brady A, Patton M. Web-neck anomaly and its association with congenital heart disease. Am J Med Genet. 1996;64:605-606.
53. Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome. Teratology. 1984;29:355-361.
54. Bakalov VK, Van PL, Brown PE, et al. Fetal lymphedema and congenital cardiac and renal anomalies in Turner syndrome. (in press)
55. Bakalov VK, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab. 2003;88:5717-5722.
56. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res. 2001;50:417-422.
57. Neely EK, Marcus R, Rosenfeld RG, et al. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab. 1993;76:861-866.
58. Shaw NJ, Rehan VK, Husain S, et al. Bone mineral density in Turner's syndrome: a longitudinal study. Clin Endocrinol (Oxf). 1997;47:367-370.
59. Carrascosa A, Gussinye M, Terradas P, et al. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res. 2000;15:2005-2010.
60. Suganuma N, Furuhashi M, Hirooka T, et al. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J. 2003;50:263-269.
61. Shaw NJ, Rehan VK, Husain S, et al. Bone mineral density in Turner's syndrome: a longitudinal study. Clin Endocrinol (Oxf). 1997;47:367-370.
62. Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med. 2003;115:259-264.
63. Davies MC, Gulekli B, Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf). 1995;43:741-746.
64. Sylven L, Hagenfeldt K, Ringertz H. Bone mineral density in middle-aged women with Turner's syndrome. Eur J Endocrinol. 1995;132:47-52.
65. Landin-Wilhelmsen K, Bryman I, Windh M, et al. Osteoporosis and fractures in Turner syndrome: importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf). 1999;51:497-502.
66. Ross JL, Long LM, Feuillan P, et al. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab. 1991;73:355-359.
67. Smith MA, Wilson J, Price WH. Bone demineralization in patients with Turner's syndrome. J Med Genet. 1982;19:100-103.
68. Ross JL, Roeltgen D, Feuillan P, et al. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology. 2000;54:164-170.
69. Ross JL, Roeltgen D, Feuillan P, et al. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab. 1998;83:3198-3204.
70. Ross JL, Stefanatos GA, Kushner H, et al. The effect of genetic differences and ovarian failure: intact cognitive function in adult women with premature ovarian failure versus turner syndrome. J Clin Endocrinol Metab. 2004;89:1817-1822.
71. Murphy DG, DeCarli C, Daly E, et al. X-chromosome effects on female brain: a magnetic resonance imaging study of Turner's syndrome. Lancet. 1993;342:1197-1200.
72. Reiss AL, Mazzocco MM, Greenlaw R, et al. Neurodevelopmental effects of X monosomy: a volumetric imaging study. Ann Neurol. 1995;38:731-738.
73. Murphy DG, Mentis MJ, Pietrini P, et al. A PET study of Turner's syndrome: effects of sex steroids and the X chromosome on brain. Biol Psychiatry. 1997;41:285-298.
74. Lawrence K, Kuntsi J, Coleman M, et al. Face and emotion recognition deficits in Turner syndrome: a possible role for X-linked genes in amygdala development. Neuropsychology. 2003;17:39-49.
75. Polychronakos C, Letarte J, Collu R, et al. Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr. 1980;96:1009-1014.
76. Cicognani A, Mazzanti L, Tassinari D, et al. Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype. Eur J Pediatr. 1988;148:64-68.
77. Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome: the impact of sex hormone replacement. Diabetes Care. 1998;21:1062-1070.
78. Caprio S, Boulware S, Diamond M, et al. Insulin resistance: an early metabolic defect of Turner's syndrome. J Clin Endocrinol Metab. 1991;72:832-836.
79. Gravholt CH, Naeraa RW. Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome. Am J Med Genet. 1997;72:403-408.
80. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab. 2001;86:4166-4170.
81. Bakalov VK, Cooley MM, Quon MJ, et al. Impaired insulin secretion in the turner metabolic syndrome. J Clin Endocrinol Metab. 2004;89:3516-3520.
82. Bakalov VK, Cooley MM, Troendle J, et al. The prevalence of diabetes mellitus in the parents of women with Turner's syndrome. Clin Endocrinol (Oxf). 2004;60:272.
83. Forbes AP, Engel E. The high incidence of diabetes mellitus in 41 patients with gonadal dysgenesis and their close relatives. Metabolism. 1963;12:428-439.
84. Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA. 2003;290:2127-2128.
85. Taylor SH. Genetic vs hormonal factors in lipid metabolism in women. JAMA. 2004;291:424-425.
86. Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf). 1998;49:447-450.
87. Sybert V. The adult patient with Turner syndrome. In: Albertsson-Winkland K, Ranke M, eds. Turner Syndrome in a Life-Span Perspective. New York, NY: Elsevier Science, BV; 1995:205-218.
88. Ostberg JE, Conway GS. Adulthood in women with Turner syndrome. Horm Res. 2003;59:211-221.
89. Conway GS. The impact and management of Turner syndrome in adult life. Best Pract Res Clin Endocrinol Metab. 2002;16:243-261.
90. Tarani L, Lampariello S, Raguso G, et al. Pregnancy in patients with Turner's syndrome: six new cases and review of literature. Gynecol Endocrinol. 1998;12:83-87.
91. Hreinsson JG, Otala M, Fridstrom M, et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002;87:3618-3623.
92. Hayward PA, Satsangi J, Jewell DP. Inflammatory bowel disease and the X chromosome. QJM. 1996;89:713-718.
93. Garavelli L, Donadio A, Banchini G, et al. Liver abnormalities and portal hypertension in Ullrich-Turner syndrome. Am J Med Genet. 1998;80:180-182.
94. Wardi J, Knobel B, Shahmurov M, et al. Chronic cholestasis associated with Turner's syndrome: 12 years of clinical and histopathological follow-up. Digestion. 2003;67:96-99.
95. Bonamico M, Pasquino AM, Mariani P, et al, and the Italian Society of Pediatric Gastroenterology Hepatology (SIGEP), Italian Study Group for Turner Syndrome (ISGTS). Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495-5498.
96. Gungor N, Boke B, Belgin E, et al. High frequency hearing loss in Ullrich-Turner syndrome. Eur J Pediatr. 2000;159:740-744.
97. Hultcrantz M. Ear and hearing problems in Turner syndrome. Acta Otolaryngol. 2003;123:253-257.
98. Chrousos GA, Ross JL, Chrousos G, et al. Ocular findings in Turner syndrome: a prospective study. Ophthalmology. 1984;91:926-928.
99. Gotoh M, Yamamoto M, Kawasaki T, et al. Two cases of unilateral retinal neovascularization in Turner syndrome. Am J Ophthalmol. 1998;126:144-146.
100. Lesniak-Karpiak K, Mazzocco MM, Ross JL. Behavioral assessment of social anxiety in females with Turner or fragile X syndrome. J Autism Dev Disord. 2003;33:55-67.
101. Lawrence K, Campbell R, Swettenham J, et al. Interpreting gaze in Turner syndrome: impaired sensitivity to intention and emotion, but preservation of social cueing. Neuropsychologia. 2003;41:894-905.
102. Barrenas M-L, Landin-Wilhelmsen K, Hanson C. Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res. 2000;144:21-28.
103. Salerno M, Di Maio S, Gasparini N, et al. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158:618-623.
104. Larizza D, Locatelli M, Vitali L, et al. Serum liver enzymes in Turner syndrome. Eur J Pediatr. 2000;159:143-148.
105. Elsheikh M, Hodgson HJ, Wass JA, et al. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol (Oxf). 2001;55:227-231.
106. Hasle H, Olsen JH, Nielsen J, et al. Occurrence of cancer in women with Turner syndrome. Br J Cancer. 1996;73:1156-1159.
107. Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet. 2000;9:695-702.
108. Munns CF, Glass IA, Flanagan S, et al. Familial growth and skeletal features associated with SHOX haploinsufficiency. J Pediatr Endocrinol Metab. 2003;16:987-996.
109. Marchini A, Marttila T, Winter A, et al. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem. 2004;279:37103-37114.
110. Vaiman D. Fertility, sex determination, and the X chromosome. Cytogenet Genome Res. 2002;99:224-228.
111. Vilain E. Anomalies of human sexual development: clinical aspects and genetic analysis. Novartis Found Symp. 2002;244:43-53.
112. Vialard F, Cocquet J, Christin-Maitre S, et al. The X chromosome and ovarian function. Cytogenet Genome Res. 2002;99:218-223.